Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/170974 
Erscheinungsjahr: 
2017
Schriftenreihe/Nr.: 
IZA Discussion Papers No. 10990
Verlag: 
Institute of Labor Economics (IZA), Bonn
Zusammenfassung: 
In response to the epidemic of prescription-drug abuse, now 49 US states have passed legislation to establish Prescription Drug Monitoring Programs (PDMPs). These programs track controlled-substance prescribing and usage behavior in an effort to improve patient outcomes and identify and preempt access by drug abusers. We exploit variation in the timing of implementation across states to identify the effectiveness of PDMPs on reducing opioid abuse. In particular, by considering the role of specific program attributes we offer the strongest evidence to date of the potential for PDMP-type policy to decrease opioid-related treatment admissions. We also consider heterogeneity across intensity and tenure of use, which reveals that the largest gains are coming from reductions in the number of less-attached users. Overall, these results have important implications for the effective re-design of PDMP policy.
Schlagwörter: 
prescription drug
drug treatment
opioid
abuse
JEL: 
I12
I18
K42
Dokumentart: 
Working Paper

Datei(en):
Datei
Größe
367.75 kB





Publikationen in EconStor sind urheberrechtlich geschützt.